A prospective trial of midwest breast cancer patients: Ap53 gene mutation is the most important predictor of adverse outcome
Year: 2000
Type: article
Study design: Observational Study
Source: International Journal of Cancer
Institution: Mayo Clinic
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2047400342
